Chief, Division of Preventive Medicine
Brigham and Women's Hospital
Boston, Massachusetts, United States
JoAnn E. Manson, MD, MPH, DrPH, FACP, is Professor of Medicine and the Michael and Lee Bell Professor of Women’s Health at Harvard Medical School, Professor in the Department of Epidemiology, Harvard T.H. Chan School of Public Health, and Chief of the Division of Preventive Medicine at Brigham and Women's Hospital (BWH). Dr. Manson is a physician epidemiologist, clinical trialist, endocrinologist, and Principal Investigator of several research studies, including the Women’s Health Initiative Clinical Center In Boston (PI since study inception in 1993); the cardiovascular component of the Harvard Nurses’ Health Study (PI for 20 years), the VITamin D and OmegA-3 TriaL (VITAL; PI with Dr. J. Buring since study inception in 2009); and the COcoa Supplement and Multivitamin Outcomes Study (COSMOS, PI with Dr. H. Sesso since 2014). Her primary research interests include randomized clinical prevention trials of nutritional and lifestyle factors related to heart disease, diabetes, and other age-related disorders, the role of endogenous and exogenous estrogens as determinants of chronic disease, and the effects of vitamin D and omega-3 fattys on health outcomes. Dr. Manson has received numerous honors, including the American Heart Association’s (AHA) Population Research Prize, the AHA’s Distinguished Scientist Award, election to the Institute of Medicine of the National Academies (National Academy of Medicine), membership in the Association of American Physicians (AAP), fellowship in AAAS, the Woman in Science Award from the American Medical Women’s Association, the Bernadine Healy Award for Visionary Leadership in Women’s Health, and the Massachusetts Medical Society awards in both Public Health and Women’s Health Research. She served as the 2011-2012 President of the North American Menopause Society. Dr. Manson has published more than 1,200 articles and is the author or editor of several books and textbooks.
Sunday, July 23, 2023
10:13 AM – 10:17 AM ET
Disclosure information not submitted.